A Missouri district court judge said stopping the FTC’s suit against Caremark, Express Scripts and Optum Rx would be “against ...

An earlier FTC report published in July 2024 argued that the six largest PBMs were effectively running a monopoly that gave them enormous power over the price of medicines and allowed them to ...

A long-awaited report from the US Federal Trade Commission (FTC) on pharmacy benefit managers (PBMs) is out – and will make uncomfortable reading for the pharma supply chain middlemen.

Below, we summarize the major findings from the Second Report, discuss potential next steps by the FTC (and others), and offer some key takeaways. In the complex world of health insurance ...

A federal judge denied a bid by CVS Health, Cigna and UnitedHealth Group to block the Federal Trade Commission's pricing case ...

Outrage against PBMs was on full display when 400 pharmacy professionals in Kansas shuttered their businesses and petitioned ...

CVS Health reported $1.6 billion in profit for the fourth quarter, down from a $2 billion haul a year ago, according to its ...

In the latest executive shakeup at CVS, the pharmacy giant has named a new president of its pharmacy benefit management ...

For years PBMs have been assailed by pharma companies and Congress, and the new Trump administration looks likely to keep up the barrage.

NEW YORK, Feb. 20, 2025 /PRNewswire/ -- Rightway, the only PBM purpose-built for transparency and fiduciary alignment, today released its 2024 PBM Annual Report, showcasing another year of ...

CVS CEO David Joyner’s comments come as lawmakers on both sides of the aisle and President Donald Trump have signaled ...

PBM reform represents a tremendous opportunity. It might be one of the only significant, consequential areas of true ...